Lyophilization Services for Biopharmaceuticals Market Report 2023-2028

[Research Report] The lyophilization services for biopharmaceuticals market is expected to grow from US$ 2,051.41 million in 2022 to US$ 3,586.55 million by 2028; it is estimated to register a CAGR of 9.9% from 2023 to 2028.

The lyophilization services for biopharmaceuticals market growth is attributed to the rising demand for lyophilized products and rapidly growing contract manufacturing and lyophilization services across the world.

The lyophilization services for biopharmaceuticals market is segmented on the basis of service type, end user, and region. The report offers insights and in-depth analysis of the market, emphasizing parameters such as lyophilization services for biopharmaceuticals market trends, technological advancements, market dynamics, and the competitive landscape analysis of leading market players.   

Lyophilization Services for Biopharmaceuticals Market –Market Insights      

Rapid Increase in Contract Manufacturing and Lyophilization Services Drives Lyophilization Services for Biopharmaceuticals Market Growth

The biopharmaceuticals market continues to expand across the world, which can be the primary growth driver for the pharmaceutical industry. Biopharmaceutical parenteral manufacturing has expanded recently as more therapeutic biologics have been approved. Biotechnology companies outsource from contract manufacturing organizations (CMOs) to meet their fill-and-finish needs and reduce the risk of microbial contamination. Biopharma companies are dependent on contract manufacturing organizations (CMOs) to provide capacity and capabilities as needed; in some cases, CMOs provide a great deal of a company’s production.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Lyophilization Services for Biopharmaceuticals Market: Strategic Insights

Lyophilization Services for Biopharmaceuticals Market

• 
  CAGR (2022 - 2028)

  9.9%
• Market Size 2022
  US$ 2.05 Billion
• Market Size 2028
  US$ 3.59 Billion

Market Dynamics

GROWTH DRIVERS

• Rising Demand for Lyophilized Products
• Rapid Growth in Contract Manufacturing and Lyophilization Services Across the World

FUTURE TRENDS

• Growth in the Number of siRNA and Antibody Based Formulations

OPPORTUNITIES

• Launch of Advanced Lyophilization Technology

Key Players

• ATTWILL Medical Solutions
• Axcellerate Pharma LLC
• Labyrinth Biopharma LLC
• Berkshire Sterile Manufacturing
• PCI Pharma Services
• Curia Global Inc
• Emergent BioSolutions Inc
• Jubilant HollisterStier LLC
• Biofortuna

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Service Type

• Lyophilization Cycle Development
• Clinical Manufacturing
• Commercial Manufacturing
• Freeze Drying Analytical Services

End User

• Pharmaceutical & Biotechnology Companies
• Research Institutes

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

 

Setting up in-house lyophilization capabilities and operations requires specialized equipment and expertise, which is an expensive and time-consuming. However, outsourcing is cheaper and increases the efficiency of manufacturing processes. Additionally, it allows biotechnology companies to redirect resources to other areas. Thus, drug developers and biopharmaceutical companies outsource such operations to CMOs to save overall production and yield cost. A few years ago, the CMO industry was a niche service market, offering additional manufacturing capacity or specific services to biotechnology companies. Now, many biotechnology companies outsource various services, from early-stage drug development to commercial-scale manufacturing. As the biotechnology industry is shifting from large-scale production to niche and targeted therapies (personalized medicine), the demand for flexible operational capabilities, production scales, and multiple-product operations is rising. Owing to all these factors, the inclination toward CMOs is growing. One such CMO that provides specialized facilities and dedicated lines for lyophilization operations is Jubilant HollisterStier Contract Manufacturing & Services. The CMO offers sterile fill/finish of Phase I through a commercial sterile injectable and a full suite of lyophilization services. To keep up with the growing demand for its services, Jubilant is installing a new 385-square-foot lyophilizer. Thus, the rising capability and availability of biopharma CMOs fuel the lyophilization services for biopharmaceuticals market growth.

Lyophilization Services for Biopharmaceuticals Market – By Service Type-Based Insights

Based on service type, the global lyophilization services for biopharmaceuticals market is segmented into commercial manufacturing, lyophilization cycle development, clinical manufacturing, and freeze drying analytical services. The commercial manufacturing segment held the largest market share in 2022. The lyophilization cycle development segment is expected to register the highest CAGR during the forecast period.

Lyophilization Services for Biopharmaceuticals Market – By End User-Based Insights

Based on end user, the global lyophilization services for biopharmaceuticals market is segmented into pharmaceutical and biotechnology companies, research institutes, and others. The pharmaceutical and biotechnology companies segment held the largest market share in 2022. The research institutes segment is expected to register the highest CAGR during the forecast period. 

Companies in the lyophilization services for biopharmaceuticals market adopt inorganic and organic strategies such as mergers and acquisitions. A few recent key market developments are listed below:

• In November 2022, LTI announced its engagement in the development, process engineering, and preparation of clinical material for the tuberculosis vaccine candidate ID93 / GLA-SE. The tuberculosis vaccine has successfully reached Phase 2 clinical testing. This study represents the first report on the successful lyophilization of a thermostable subunit vaccine candidate containing an emulsion-based adjuvant.
• In May 2022, Jubilant HollisterStier LLC entered into a cooperative agreement for US$149.6 million with the Army Contracting Command, in coordination with the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEOCBRND) on behalf of the Biomedical Advanced Research and Development Authority (BARDA), within the US Department of Health and Human Services.
• In October 2021, PCI Pharma Services (PCI) announced that they have signed a definitive agreement to acquire Lyophilization Services of New England, Inc. (LSNE), a premier contract development and manufacturing organization (CDMO) headquartered in Bedford, New Hampshire, from global private equity firm Permira. The acquisition adds five FDA-approved facilities in the US (New Hampshire, Wisconsin) and Europe (Spain), with a sixth expecting approval over the coming months. In addition, three additional facilities are under development. These facilities will strengthen their global 30-site network.
• In July 2021, Albany Molecular Research, Inc. (AMRI) announced that it is changing its name to Curia, effective July 12, 2021. The new name reinforces the company’s strategic positioning as an end-to-end global CDMO, applying its scientific expertise and extensive capabilities from research and development (R&D) to commercial manufacturing to enable its pharmaceutical and biotechnology customers to advance important new products that improve lives.     

Lyophilization Services for Biopharmaceuticals Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Company Profiles - Lyophilization Services for Biopharmaceuticals Market

• ATTWILL Medical Solutions
• Axcellerate Pharma LLC
• Labyrinth Biopharma LLC
• Berkshire Sterile Manufacturing
• PCI Pharma Services
• Curia Global Inc
• Emergent BioSolutions Inc
• Jubilant HollisterStier LLC
• Biofortuna
• Lyophilization Technology Inc.
• SYNERLAB GROUP